GlassScriptPhysician profile
Jesus A Yanes
NPI 1033344999
$8,119.91
in general payments reported to CMS, 2019-2025
21 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $310 · 2021: $576 · 2022: $637 · 2023: $864 · 2024: $2,518 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,917.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,324.21 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $2,046.53 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $721.06 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $702.33 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $645.16 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $516.56 | 2024-2025 | |
| Dexcom, INC. | $353.78 | 2024-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Amgen INC. | $236.09 | 2024-2025 | Repatha, Otezla, Repatha |
| Medtronic USA, INC. | $156.27 | 2019 | |
| Angiodynamics, INC. | $140.42 | 2022 | |
| Mannkind Corporation | $38.19 | 2024 | |
| Glaxosmithkline, LLC. | $36.41 | 2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Shield Therapeutics INC | $35.52 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $26.09 | 2025 | |
| Phadia US INC. | $24.30 | 2025 | Immunocap |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.91 | 2024 | Freestyle Libre 3 |
| Hologic Sales and Service, LLC | $23.08 | 2019 | |
| Antares Pharma, INC. | $20.83 | 2024 | Xyosted |
| Exact Sciences Corporation | $17.09 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.25 | 2025 | Jardiance |
| Xeris Pharmaceuticals, INC. | $15.83 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesus Yanes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.